AMIT DHIR: Open Payments
NPI 1518498021 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$42,580 in 106 payments from 4 companies in 2025. Trend: 2023 $23,159 · 2024 $29,324 · 2025 $42,580
Speaker / faculty: $29,198Travel & lodging: $7,095Food & beverage: $3,940Consulting: $2,320Long term medical supply or device loan: $28
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 67 | $30,178 |
| ViiV Healthcare Company | 37 | $12,336 |
| Merck Sharp & Dohme LLC | 1 | $38 |
| Baxter Healthcare | 1 | $28 |
Products named: APRETUDE, Biktarvy, Descovy, Yeztugo, CABENUVA, Hillrom - ELI 280.
Industry payments across MD — which companies pay providers there.
